A Study to Investigate How Effective and Safe Solifenacin Succinate Suspension is in Treating Children/Adolescents Aged 5 to Less Than 18 Years With Symptoms of Overactive Bladder (OAB) Compared to a Non-active Drug
Clinical trial NCT01565707 · COMPLETED
Trial details
- NCT number
- NCT01565707
- Sponsor
- Astellas Pharma Europe B.V.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-07
- Primary completion
- 2013-12-31
- Enrollment
- 189
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.